Equities analysts expect Xylem Inc (NYSE:XYL) to report $999.71 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Xylem’s earnings. The lowest sales estimate is $961.00 million and the highest is $1.05 billion. Xylem posted sales of $1.35 billion during the same quarter last year, which suggests a negative year-over-year growth rate of 25.9%. The company is expected to issue its next quarterly earnings report on Thursday, August 6th.
On average, analysts expect that Xylem will report full-year sales of $4.63 billion for the current year, with estimates ranging from $4.33 billion to $5.41 billion. For the next fiscal year, analysts anticipate that the company will report sales of $5.03 billion, with estimates ranging from $4.72 billion to $5.68 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Xylem.
Xylem (NYSE:XYL) last released its earnings results on Tuesday, May 5th. The industrial products company reported $0.23 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.14). Xylem had a return on equity of 17.08% and a net margin of 7.01%. The company had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the previous year, the company posted $0.52 EPS. The business’s revenue was down 9.2% on a year-over-year basis.
Several hedge funds have recently modified their holdings of XYL. Filbrandt Wealth Management LLC bought a new stake in shares of Xylem in the fourth quarter valued at approximately $33,000. Balentine LLC bought a new stake in Xylem during the first quarter worth $33,000. Signaturefd LLC lifted its stake in Xylem by 60.2% during the first quarter. Signaturefd LLC now owns 564 shares of the industrial products company’s stock worth $37,000 after purchasing an additional 212 shares during the last quarter. Meeder Asset Management Inc. lifted its stake in Xylem by 69.4% during the fourth quarter. Meeder Asset Management Inc. now owns 488 shares of the industrial products company’s stock worth $38,000 after purchasing an additional 200 shares during the last quarter. Finally, Clean Yield Group bought a new stake in Xylem during the first quarter worth $39,000. Institutional investors and hedge funds own 85.88% of the company’s stock.
NYSE XYL traded up $1.00 during trading on Friday, reaching $63.16. 3,189,624 shares of the company’s stock were exchanged, compared to its average volume of 1,345,259. The business has a 50 day moving average price of $64.78 and a 200-day moving average price of $73.37. The stock has a market capitalization of $11.18 billion, a P/E ratio of 31.74, a PEG ratio of 4.35 and a beta of 1.02. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.55 and a quick ratio of 1.19. Xylem has a fifty-two week low of $54.62 and a fifty-two week high of $89.34.
The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend was Wednesday, May 27th. Xylem’s dividend payout ratio (DPR) is currently 34.44%.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Recommended Story: Key terms to understand channel trading
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.